Bentham Science Publishers Ltd.
Therapeutic Potential of Sodium-glucose Co-transporter-2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists for Patients with Acute Coronary Syndrome: A Review of Clinical Evidence
:
Atherosclerotic Cardiovascular Disease (ASCVD) is still one of the leading causes of death globally,
with Coronary Artery Disease (CAD) being the most prevalent form of ASCVD. Patients with type 2 Diabetes
Mellitus (DM) experience an increased risk for ASCVD during the disease course, with CAD being the
most common cause of death among affected individuals, resulting in shorter life expectancy and increased
morbidity among survivors. Recently, 2 novel classes of anti-diabetic drugs, namely Sodium-Glucose...
Preuzmite dokument
2024
Paschalis Karakasis
,
Manfredi Rizzo
,
Nikolaos Fragakis
,
Theocharis Koufakis
,
Michael Doumas
,
Aleksandra Klisic
,
Dimitrios Patoulias
,
George Kassimis